Another research study presented at ACR meeting also indicates that people with RA have an increased risk of heart problems as those without RA. [...]
|
|||||||
|
Another research study presented at ACR meeting also indicates that people with RA have an increased risk of heart problems as those without RA. [...] Researchers from the Barts and the London School of Medicine have found tiny structures in joints, which form as a response to the inflammation, that operate similarly to antibody-producing lymph nodes. [...] Tumor necrosis factor (TNF) has been identified as having a key responsibility in many inflammatory diseases, including rheumatoid arthritis (RA). There has been substantial research into the early signaling pathways activated by TNF, but there is not much known about the delayed and chronic TNF responses. In addition, cells called macrophages (cells within the [...] I have reported here previously about the advances in arthritis genetic research and the hopes that these studies would provide the basis for potential treatment options. Now researchers have reported that clinical studies show that gene therapy reduces rheumatoid arthritis (RA) patient’s symptoms. [...] Researchers at Imperial College London (officially The Imperial College of Science, Technology and Medicine) have identified a protein that acts as a “master switch” for certain white blood cells to govern whether they increase or impede inflammation. The results of this study could lead to the development of new treatments for inflammatory diseases, such [...] A team of researchers St. James Hospital in Dublin, Ireland, conducted a study that found the erectile dysfunction (ED) has a higher prevalence in men who have rheumatoid arthritis (RA). Previous studies have linked erectile dysfunction to vascular events, such as stroke and heart attacks, but this study indicates that there is also a [...] In April of 2007, NICE recommended that if a rheumatoid arthritis (RA) patient did not respond to 1 of 3 approved anti-tumor necrosis factor (TNF) drugs they could not try one of the others. But after months of campaigning by 2,000 members of the National Rheumatoid Arthritis Society, drug companies and patients groups, NICE has agreed to reconsider its previous recommendation. [...] |
|||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||